-
EP3058940
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3058940
| EP3058940 - Quinoline derivatives for use in the treatment or prevention of viral infection [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.09.2017 Database last updated on 30.03.2026 | |
| Former | The application has been published Status updated on 11.04.2017 | Most recent event Tooltip | 01.09.2017 | Application deemed to be withdrawn | published on 04.10.2017 [2017/40] | Applicant(s) | For all designated states ABIVAX 5 rue de la Baume 75008 Paris / FR | For all designated states CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 3, rue Michel-Ange 75794 Paris Cedex 16 / FR | For all designated states Institut Curie 26, rue d'Ulm 75248 Paris Cedex 05 / FR | For all designated states Université Montpellier 163 Rue Auguste Broussonnet 34090 Montpellier / FR | [2016/34] | Inventor(s) | 01 /
Scherrer, Didier 26 avenue des sabines 34170 Castelnau le Lez / FR | 02 /
Garcel, Aude 5 avenue Monteroni d'Arbia Le Palais Vinci DO2 34920 Le Crès / FR | 03 /
Campos, Noelie 20, rue des Droits de l'Homme Résidence Villa Borghese A32 34920 Le Crès / FR | 04 /
Tazi, Jamal 4 rue Condorcet 34380 Clapiers / FR | 05 /
Vautrin, Audrey 462 avenue de l'Europe (appt B15) 34170 Castelnau le Lez / FR | 06 /
Mahuteau-Betzer, Florence 36 avenue Hoche 78470 Saint Rémy lès Chevreuses / FR | 07 /
Najman, Romain 29b rue du 11 novembre 1918 94240 L'Hay les Roses / FR | 08 /
Fornarelli, Pauline 13 rue des 4 cantons 91140 Villebon-sur-Yvette / FR | [2016/34] | Representative(s) | Ipsilon 11 rue Saint-Georges 75009 Paris / FR | [N/P] |
| Former [2016/34] | Nony 11 rue Saint-Georges 75009 Paris / FR | Application number, filing date | 15305277.4 | 23.02.2015 | [2016/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3058940 | Date: | 24.08.2016 | Language: | EN | [2016/34] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 04.05.2015 | Classification | IPC: | A61K31/4709, A61P31/18 | [2016/34] | CPC: |
A61K31/47 (EP,RU,US);
A61K31/4725 (KR);
A61K31/4709 (EP,KR,US);
A61K31/706 (EP,RU,US);
A61P31/12 (EP);
A61P31/18 (EP,RU);
C07D215/38 (RU);
C07D401/12 (RU);
C07D405/12 (RU);
A61K2300/00 (KR)
(-)
| C-Set: |
A61K31/4709, A61K2300/00 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/34] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | Chinolin-Derivate zur Behandlung oder Vorbeugung von viralen Infektionen | [2016/34] | English: | Quinoline derivatives for use in the treatment or prevention of viral infection | [2016/34] | French: | Dérivés de quinoline utilisés dans le traitement ou la prévention d'une infection virale | [2016/34] | Examination procedure | 25.02.2017 | Application deemed to be withdrawn, date of legal effect [2017/40] | 12.04.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2017/40] | Fees paid | Penalty fee | Additional fee for renewal fee | 28.02.2017 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I] WO2015001518 (SPLICOS et al.) | [ID] WO2010143169 (SPLICOS SOC et al.) | [I] EP2757161 (SPLICOS et al.) | [ID] EP2465502 (SPLICOS SOC et al.) | by applicant | WO2010143169 | WO2012080953 | EP14306164 | EP14306166 | EP15305274 | PINAR IYODOGAN ET AL.: "Current Perspectives on HIV-1 Antiretroviral Drug Resistance", VIRUSES, vol. 6, 2014, pages 4095 - 4139 | WU ET AL.: "Fast and SNP-tolerant detection of complex variants and splicing in short reads", BIOINFORMATICS, vol. 26, 2010, pages 873 - 881 | DENTON ET AL.: "Humanized mouse models of HIV infection", AIDS REV, vol. 13, 2011, pages 135 - 148 | BERGES ET AL.: "The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment", RETROVIROLOGY, vol. 8, 2011, pages 65 | NISCHANG ET AL.: "Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1", PLOS ONE, vol. 7, 2012, pages E38853 | MCDOUGAL: "Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV", J. IMMUNOL. METHODS, vol. 76, 1985, pages 171 - 183 | NISCHANG ET AL.: "Humanized mice recapitulate key features of HIV- infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1", PLOS ONE, vol. 7, 2012, pages E38853 | BAKKOUR ET AL.: "Small-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistance", PLOS PATHOG, vol. 3, 2007, pages 1530 - 1539 | KLINCK ET AL.: "Multiple alternative splicing markers for ovarian cancer", CANCER RES., vol. 68, 2008, pages 657 - 663 | VENABLES ET AL.: "Cancer-associated regulation of alternative splicing", NAT. STRUCT. MOL. BIOL., vol. 16, 2009, pages 670 - 676 |